Hjem › Mesoteliom › Washington
Kliniske studier for Mesoteliom i Washington, DC
9 studier for Mesoteliom søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
Mesoteliom-studier i andre byer
- Houston, TX15 studier
- New York City, NY10 studier
- Chicago, IL9 studier
- Boston, MA8 studier
- Nashville, TN8 studier
- Los Angeles, CA6 studier
- Arlington, VA6 studier
- Pittsburgh, PA6 studier
- Philadelphia, PA6 studier
- Seattle, WA6 studier
- Edison, NJ5 studier
- Rochester, MN5 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.